Abacavir Base (CAS number 188062-50-2) is a powerful antiviral typically utilized in the treatment of HIV disease and related additional infections . It functions as a nucleoside-like blocker , interfering with the pathogen's reproduction process . Administered often in conjunction other antiretroviral compounds, abacavir plays a key part in controlling the amount of virus and improving individual health . Careful HLA screening for the B5701 allele is necessary prior to initiation of this regimen to avoid the risk of a hypersensitivity reaction .
Abarelix (183552-38-7): Properties and Functions
Abarelix, identified by the CAS Registry Number 183552-38-7, is a laboratory-created protein modulator of gonadotropin-releasing hormone (GnRH). This key property lies in its ability to initially stimulate, then rapidly desensitize GnRH receptors, leading to a substantial lessening in gonadotropin secretion. Therapeutically, abarelix is employed primarily in the management of advanced prostate disease; however, studies also explores potential uses in other hormonal imbalances and reproductive health . The compound 's composition allows for selective receptor interaction .
```text
Abiraterone Acetate (154229-18-2): Synthesis and Analytical Data
The preparation of Abiraterone Acetate, identified by the Chemical Abstracts Service Registry Number 154229-18-2, involves intricate multistep organic routes. Several described methods exist, often beginning with Androstadienedione and utilizing selective oxidation and esterification steps. A typical method includes protecting group strategies to ensure intended regioselectivity. Analytical information, crucial for purity control, routinely employs liquid chromatography (HPLC) for determination of content. Nuclear Magnetic Resonance (NMR) examination confirms the structural identity. Mass measurement supplies molecular weight verification. Other techniques, like infrared (IR) analysis, assist in assessment and are critical for batch release.
- Synthesis Routes
- Quality Control
- Structural Characterization
```
```text
Understanding the CAS Numbers of Abacavir, Abarelix, and Abiraterone Acetate
Identifying chemical substances accurately is paramount in fields like medicine, research, and manufacturing. A crucial tool for this identification is the Chemical Abstracts Service (CAS) registry number – a unique numerical identifier assigned to every distinct chemical compound. Let's examine the CAS numbers for three significant pharmaceuticals: Abacavir, Abarelix, and Abiraterone Acetate. Knowing these identifiers aids in precise referencing and prevents ambiguity within scientific literature and regulatory documentation. Abacavir, a nucleoside reverse transcriptase inhibitor used to treat HIV, holds the CAS number 60242-78-0. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor antagonist employed in prostate cancer treatment, is identified by the CAS number 5490-02-9. Finally, Abiraterone Acetate a CYP17 inhibitor used in metastatic prostate cancer, possesses the CAS number 857342-50-7. Correctly utilizing these numbers ensures clarity and accuracy when discussing these medications.
- The Antiretroviral CAS Number: 60242-78-0
- Compound B CAS Number: 5490-02-9
- The CYP17 Inhibitor CAS Number: 857342-50-7
```
Essential Facts on Abacavir , Abarelix , and Abiraterone Acetate
These medications represent distinct solutions in medicine. Abacavir is a medicine primarily used to manage HIV disease , often alongside other antiretroviral . ACITAZANOLAST 114607-46-4 Abarelix Injection is a medication that functions as a GnRH antagonist , typically prescribed to reduce prostate growths before operation . Lastly, Abiraterone Drug is another therapy administered to manage advanced prostate malignancies , specifically targeting testosterone synthesis . Please ask a physician for complete information and instructions regarding any drug.
Pharmaceutical Analysis: Abacavir Salt, Abarelix Product, Abiraterone Drug and Their CAS Codes
Examining various pharmaceutical medications necessitates the clear recognition. Particularly, Abacavir Sulfate, applied in HIV treatment, carries a Registration Code of 3870-92-6. Likewise, Abarelix, the GnRH blocker administered in prostate growths treatment, displays the Registration Code 64347-82-2. Lastly, Abiraterone Acetate, a compound to advanced prostate cancer, can be identified with the CAS Code 864930-63-3. These identifiers are essential resources to correct pharmaceutical referencing and study.